Australia seems poised to experience innovative medication for weight issues: Retatrutide. This dual molecule – working on both GLP-1 and GIP receptors – has remarkable outcomes in global trials, indicating meaningful reductions in body fat. While availability is pending with Australian regulators, a number of people dealing with weight-related… Read More